FBLN1
Fibulin-1
Also known as: FBLN, FBLN1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P23142
- Gene
- FBLN1
- Ensembl
- ENSG00000077942
- Chromosome
- 22
- Canonical length
- 703 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins
- Subcellular location
- Endoplasmic reticulum
- Secretome location
- Secreted to extracellular matrix
- Quaternary structure
- Homomultimer
OverviewNCBI Gene
Fibulin 1 is a secreted glycoprotein that becomes incorporated into a fibrillar extracellular matrix. Calcium-binding is apparently required to mediate its binding to laminin and nidogen. It mediates platelet adhesion via binding fibrinogen. Four splice variants which differ in the 3' end have been identified. Each variant encodes a different isoform, but no functional distinctions have been identified among the four variants. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
703 residues, UniProt reviewed canonical sequence.
>P23142|FBLN1
1 MERAAPSRRV PLPLLLLGGL ALLAAGVDAD VLLEACCADG HRMATHQKDC SLPYATESKE
61 CRMVQEQCCH SQLEELHCAT GISLANEQDR CATPHGDNAS LEATFVKRCC HCCLLGRAAQ
121 AQGQSCEYSL MVGYQCGQVF QACCVKSQET GDLDVGGLQE TDKIIEVEEE QEDPYLNDRC
181 RGGGPCKQQC RDTGDEVVCS CFVGYQLLSD GVSCEDVNEC ITGSHSCRLG ESCINTVGSF
241 RCQRDSSCGT GYELTEDNSC KDIDECESGI HNCLPDFICQ NTLGSFRCRP KLQCKSGFIQ
301 DALGNCIDIN ECLSISAPCP IGHTCINTEG SYTCQKNVPN CGRGYHLNEE GTRCVDVDEC
361 APPAEPCGKG HRCVNSPGSF RCECKTGYYF DGISRMCVDV NECQRYPGRL CGHKCENTLG
421 SYLCSCSVGF RLSVDGRSCE DINECSSSPC SQECANVYGS YQCYCRRGYQ LSDVDGVTCE
481 DIDECALPTG GHICSYRCIN IPGSFQCSCP SSGYRLAPNG RNCQDIDECV TGIHNCSINE
541 TCFNIQGGFR CLAFECPENY RRSAATLQQE KTDTVRCIKS CRPNDVTCVF DPVHTISHTV
601 ISLPTFREFT RPEEIIFLRA ITPPHPASQA NIIFDITEGN LRDSFDIIKR YMDGMTVGVV
661 RQVRPIVGPF HAVLKLEMNY VVGGVVSHRN VVNVHIFVSE YWFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FBLN1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 1,775 nTPM
Expression across tissuesHPA
Tissue
- choroid plexus: 1,775 nTPM
- cervix: 1,099 nTPM
- vagina: 909 nTPM
- heart muscle: 749 nTPM
- urinary bladder: 744 nTPM
- gallbladder: 634 nTPM
Single-cell type
- fibroblasts: 1,820 nCPM
- syncytiotrophoblasts: 1,557 nCPM
- decidual stromal cells: 1,117 nCPM
- extravillous trophoblasts: 994 nCPM
- cytotrophoblasts: 846 nCPM
- migrating cytotrophoblasts: 731 nCPM
Immune cell
- non-classical monocyte: 2.5 nTPM
- plasmacytoid DC: 1.2 nTPM
- myeloid DC: 0.5 nTPM
- basophil: 0.4 nTPM
- intermediate monocyte: 0.3 nTPM
- neutrophil: 0.2 nTPM
Brain region
- choroid plexus: 1,731 nTPM
- hippocampal formation: 129 nTPM
- basal ganglia: 92 nTPM
- cerebral cortex: 87 nTPM
- cerebellum: 87 nTPM
- midbrain: 83 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.34
- gnomAD pLI
- 0.92
- gnomAD missense Z
- 1.43
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- blood coagulation, fibrin clot formation
- embryo implantation
- extracellular matrix organization
- negative regulation of cell adhesion
- negative regulation of cell motility
- negative regulation of ERK1 and ERK2 cascade
- negative regulation of protein phosphorylation
- negative regulation of stem cell proliferation
- negative regulation of substrate adhesion-dependent cell spreading
- negative regulation of transforming growth factor beta production
- positive regulation of fibroblast proliferation
- positive regulation of gene expression
- positive regulation of substrate-dependent cell migration, cell attachment to substrate
- negative regulation of transformation of host cell by virus
Molecular functions
- calcium ion binding
- extracellular matrix structural constituent
- fibrinogen binding
- fibronectin binding
- identical protein binding
- integrin binding
- peptidase activator activity
- protein-containing complex binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Anaphylatoxin/fibulin
- EGF-type aspartate/asparagine hydroxylation site
- EGF-like domain
- EGF-like calcium-binding domain
- Growth factor receptor cysteine-rich domain superfamily
- EGF-like calcium-binding, conserved site
- Complement Clr-like EGF domain
- NOTCH1, EGF-like calcium-binding domain
- Nephronectin domain-containing protein
- Fibulin, C-terminal Ig-like domain
- Anaphylotoxin-like domain
- Calcium-binding EGF domain
- Complement Clr-like EGF-like
- Fibulin C-terminal Ig-like domain
- Fibulin-1
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of FBLN1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FBLN1 as an antibody target. Whether an autoantibody or antibody against FBLN1 could matter depends on whether native FBLN1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FBLN1 is annotated as secreted, so native FBLN1 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label FBLN1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...